Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND‐HF

We aimed to characterize abnormal liver function tests in patients with heart failure (HF), as they are commonly encountered yet poorly defined.

[1]  V. Harjola,et al.  Acute Heart Failure , 2018, Update in Intensive Care and Emergency Medicine.

[2]  P. Heidenreich,et al.  Effect of minor liver function test abnormalities and values within the normal range on survival in heart failure. , 2015, The American journal of cardiology.

[3]  Mark D. Huffman,et al.  AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .

[4]  P. Ponikowski,et al.  Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study. , 2014, Journal of cardiac failure.

[5]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[6]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[7]  G. Felker,et al.  Cardiohepatic interactions in heart failure: an overview and clinical implications. , 2013, Journal of the American College of Cardiology.

[8]  M. Vaduganathan,et al.  The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry , 2013, European heart journal. Acute cardiovascular care.

[9]  V. Hasselblad,et al.  Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF , 2013, European journal of heart failure.

[10]  A. Cohen-Solal,et al.  Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. , 2013, European heart journal.

[11]  C. Ayers,et al.  Relationship of Right- to Left-Sided Ventricular Filling Pressures in Advanced Heart Failure: Insights From the ESCAPE Trial , 2013, Circulation. Heart failure.

[12]  P. Ponikowski,et al.  Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. , 2013, Journal of the American College of Cardiology.

[13]  K. Swedberg,et al.  Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial , 2012, European journal of heart failure.

[14]  H. Ulmer,et al.  Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance , 2012, European journal of clinical investigation.

[15]  U. Baumann,et al.  Central venous pressure and impaired renal function in patients with acute heart failure , 2011, European journal of heart failure.

[16]  J. A. Llompart-Pou,et al.  Hypoxic hepatitis in critically ill patients: incidence, etiology and risk factors for mortality , 2011, Journal of Anesthesia.

[17]  G. Felker,et al.  Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. , 2010, International journal of cardiology.

[18]  D. J. Veldhuisen,et al.  Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality , 2010, European journal of heart failure.

[19]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[20]  H. Ulmer,et al.  Prevalence and Prognostic Significance of Elevated &ggr;-Glutamyltransferase in Chronic Heart Failure , 2009, Circulation. Heart failure.

[21]  C. Madl,et al.  Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients , 2009, Intensive Care Medicine.

[22]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[23]  M. Pfeffer,et al.  Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program , 2009, European journal of heart failure.

[24]  V. Hasselblad,et al.  Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). , 2009, American heart journal.

[25]  Luigi Tavazzi,et al.  Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.

[26]  A. Kratz,et al.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. , 2004, The New England journal of medicine.

[27]  A. Delannoy,et al.  Hypoxic Hepatitis: Clinical and Hemodynamic Study in 142 Consecutive Cases , 2003, Medicine.

[28]  H Ector,et al.  Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. , 2001, The New England journal of medicine.

[29]  D. Rockey,et al.  Ischemic hepatitis: clinical presentation and pathogenesis. , 2000, The American journal of medicine.

[30]  W. Frishman,et al.  Cardiovascular Drug Therapy in Patients with Hepatic Diseases and Patients with Congestive Heart Failure , 2000, Journal of clinical pharmacology.

[31]  R. Cody,et al.  Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. , 1987, Archives of internal medicine.

[32]  S. Kaul,et al.  Assessment of right ventricular function using two-dimensional echocardiography. , 1984, American heart journal.

[33]  E. Vesell,et al.  Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug. , 1978, The American journal of medicine.

[34]  S. Werns.  Effect of Nesiritide in Patients with Acute Decompensated Heart Failure , 2012 .

[35]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[36]  H. Hillege,et al.  Abnormal liver function in relation to hemodynamic profile in heart failure patients. , 2010, Journal of cardiac failure.

[37]  R. Alagappan.  Laboratory Reference Values , 2009 .

[38]  O. Descamps,et al.  Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. , 1994, Journal of hepatology.

[39]  W. Abelmann,et al.  [Cardiac decompensation]. , 1968, Giornale di clinica medica.